Neutra Corp
Neutra Corp. researches, develops, and provides hemp-derived products in the nutraceutical space in the United States. The company sells hemp-derived products, including products containing delta-8-THC and other cannabinoids, CBD sports creams, and other products. Neutra Corp. was incorporated in 2011 and is based in Houston, Texas.
Neutra Corp (NTRR) - Net Assets
Latest net assets as of October 2025: $-557.98K USD
Based on the latest financial reports, Neutra Corp (NTRR) has net assets worth $-557.98K USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($213.78K) and total liabilities ($771.76K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-557.98K |
| % of Total Assets | -261.0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Neutra Corp - Net Assets Trend (2012–2025)
This chart illustrates how Neutra Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Neutra Corp (2012–2025)
The table below shows the annual net assets of Neutra Corp from 2012 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-01-31 | $-1.08 Million | -11.23% |
| 2024-01-31 | $-970.68K | -31.42% |
| 2023-01-31 | $-738.62K | +27.80% |
| 2022-01-31 | $-1.02 Million | -26.12% |
| 2021-01-31 | $-811.18K | +4.51% |
| 2020-01-31 | $-849.49K | +23.16% |
| 2019-01-31 | $-1.11 Million | -44.62% |
| 2018-01-31 | $-764.47K | -13.16% |
| 2017-01-31 | $-675.56K | -58.84% |
| 2016-01-31 | $-425.30K | -10.19% |
| 2015-01-31 | $-385.95K | +23.54% |
| 2014-01-31 | $-504.76K | -90.20% |
| 2013-01-31 | $-265.38K | -684.76% |
| 2012-01-31 | $-33.82K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Neutra Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1180153800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (January 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.92 Million | % |
| Other Comprehensive Income | $50.00K | % |
| Other Components | $7.75 Million | % |
| Total Equity | $-1.08 Million | 100.00% |
Neutra Corp Competitors by Market Cap
The table below lists competitors of Neutra Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Primotec Group Ltd
TA:PRMG
|
$579.75K |
|
KONE -B-
BE:KC4
|
$579.81K |
|
CO2 Energy Transition Corp. Warrant
NASDAQ:NOEMW
|
$579.97K |
|
Dragon Mountain Gold Ltd
AU:DMG
|
$580.15K |
|
Cashmere Valley Bank
OTCQX:CSHX
|
$579.56K |
|
MYNARIC AG SP.ADS/025
F:M0YA
|
$579.40K |
|
Queenco-L
TA:QNCO
|
$579.36K |
|
Gomero Group AB (Publ)
F:EO8
|
$578.64K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Neutra Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -970,678 to -1,079,701, a change of -109,023.
- Net loss of 109,023 reduced equity.
- Other comprehensive income increased equity by 50,000.
- Other factors decreased equity by 50,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-109.02K | -10.1% |
| Other Comprehensive Income | $50.00K | +4.63% |
| Other Changes | $-50.00K | -4.63% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Neutra Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-01-31 | $1.00 | $0.00 | x |
| 2012-01-31 | $-3.07 | $0.00 | x |
| 2013-01-31 | $-5.67 | $0.00 | x |
| 2014-01-31 | $-2.62 | $0.00 | x |
| 2015-01-31 | $-0.68 | $0.00 | x |
| 2016-01-31 | $-0.37 | $0.00 | x |
| 2017-01-31 | $-0.32 | $0.00 | x |
| 2018-01-31 | $-0.15 | $0.00 | x |
| 2019-01-31 | $-0.07 | $0.00 | x |
| 2020-01-31 | $0.00 | $0.00 | x |
| 2021-01-31 | $0.00 | $0.00 | x |
| 2022-01-31 | $0.00 | $0.00 | x |
| 2023-01-31 | $0.00 | $0.00 | x |
| 2024-01-31 | $0.00 | $0.00 | x |
| 2025-01-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Neutra Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -160.19%
- • Asset Turnover: 176.77x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-77.83K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-339.22K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.21 Million |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.86 Million |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $1.49 Million |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-800.33K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-442.58K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.32 Million |
| 2020 | 0.00% | -16205.19% | 0.04x | 0.00x | $-951.37K |
| 2021 | 0.00% | -5564.16% | 0.05x | 0.00x | $-457.88K |
| 2022 | 0.00% | -687.86% | 0.70x | 0.00x | $-530.62K |
| 2023 | 0.00% | -825.66% | 0.90x | 0.00x | $-487.56K |
| 2024 | 0.00% | -590.54% | 13.87x | 0.00x | $-136.40K |
| 2025 | 0.00% | -160.19% | 176.77x | 0.00x | $-1.05K |
Industry Comparison
This section compares Neutra Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Neutra Corp (NTRR) | $-557.98K | 0.00% | N/A | $579.75K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |